We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+19.09%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.27B
AUM Growth
-$5.76B
Cap. Flow
-$1.51B
Cap. Flow %
-46.09%
Top 10 Hldgs %
34.23%
Holding
5,681
New
749
Increased
1,274
Reduced
3,081
Closed
446

Sector Composition

Rank Sector Weight
1 Technology 9.66%
2 Financials 8.46%
3 Healthcare 8.24%
4 Consumer Discretionary 7.74%
5 Industrials 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WBND
4926
DELISTED
Western Asset Total Return ETF
WBND
$2K ﹤0.01%
+15
New +$1.5K
XNTK icon
4927
State Street SPDR NYSE Technology ETF
XNTK
$2.22B
$2K ﹤0.01%
13
-1,428
-99% -$183K
YRD
4928
Yiren Digital
YRD
$109M
$2K ﹤0.01%
+583
New +$1.99K
YYY icon
4929
Amplify CEF High Income ETF
YYY
$742M
$2K ﹤0.01%
100
ZTR
4930
Virtus Total Return Fund
ZTR
$337M
$2K ﹤0.01%
200
-19
-9% -$156
GPUS
4931
Hyperscale Data Inc
GPUS
$55.4M
0
QVCGB
4932
DELISTED
QVC Group, Inc. Series B Common Stock
QVCGB
$2K ﹤0.01%
+4
New +$1.83K
ENLC
4933
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$2K ﹤0.01%
506
-8,345
-94% -$27.3K
CERE
4934
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$2K ﹤0.01%
+100
New +$1.3K
CEM
4935
DELISTED
ClearBridge MLP and Midstream Fund Inc.
CEM
$2K ﹤0.01%
99
-389
-80% -$5.9K
SALM
4936
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$2K ﹤0.01%
1,987
+737
+59% +$746
AEY
4937
DELISTED
ADDvantage Technologies Group
AEY
$2K ﹤0.01%
80
-349
-81% -$8.88K
ACER
4938
DELISTED
Acer Therapeutics Inc
ACER
$2K ﹤0.01%
+900
New +$2.42K
CANO
4939
DELISTED
Cano Health, Inc.
CANO
$2K ﹤0.01%
+1
New +$1.14K
BOAC
4940
DELISTED
Bluescape Opportunities Acquisition Corp.
BOAC
$2K ﹤0.01%
+181
New +$1.92K
LMNL
4941
DELISTED
Liminal BioSciences Inc. Common Shares
LMNL
$2K ﹤0.01%
40
PLXP
4942
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$2K ﹤0.01%
438
-3,084
-88% -$13.6K
FPAC.U
4943
DELISTED
Far Peak Acquisition Corporation Units, each consisting of one Class A ordinary share, and one-third of one redeemable warrant
FPAC.U
$2K ﹤0.01%
+200
New +$2.04K
VIVE
4944
DELISTED
VIVEVE MED INC
VIVE
$2K ﹤0.01%
+433
New +$2.18K
CRHC.U
4945
DELISTED
Cohn Robbins Holdings Corp. Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
CRHC.U
$2K ﹤0.01%
200
LUXAU
4946
DELISTED
Lux Health Tech Acquisition Corp. Units
LUXAU
$2K ﹤0.01%
+192
New +$2.06K
PMVC.U
4947
DELISTED
PMV Consumer Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
PMVC.U
$2K ﹤0.01%
+150
New +$1.51K
NMMC
4948
DELISTED
North Mountain Merger Corp. Class A Common Stock
NMMC
$2K ﹤0.01%
+148
New +$1.52K
GOAC
4949
DELISTED
GO Acquisition Corp. Class A Common Stock
GOAC
$2K ﹤0.01%
+192
New +$1.89K
XPOA.U
4950
DELISTED
DPCM Capital, Inc. Units, each consisting of one share of Class A common stock and one-third of one
XPOA.U
$2K ﹤0.01%
+200
New +$2.06K

Similar funds

Tower Research Capital (TRC)'s Q4 2020 Portfolio in Review

As of Q4 2020, Tower Research Capital (TRC) held 5,681 positions worth $3.27B, down 64% from $9.03B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $1.51B in Q4 2020, closing 446 positions and reducing 3,081 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 6.3% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 ETF worth $24.4M.

  • Tower Research Capital (TRC)'s largest Q4 2020 buy was iShares Russell 1000 ETF: 115,321 shares worth $24.4M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $99.8M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $36.3M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q4 2020, selling an estimated $13.7M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $3.27B portfolio in Q4 2020.
  • Tower Research Capital (TRC) opened 749 new positions and closed 446 in Q4 2020.
  • Tower Research Capital (TRC)'s portfolio value fell 64% quarter-over-quarter to $3.27B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2020, filed 16 Feb 2021.